204 related articles for article (PubMed ID: 6142756)
1. Chronic GM1 ganglioside treatment reduces dopamine cell body degeneration in the substantia nigra after unilateral hemitransection in rat.
Toffano G; Savoini GE; Moroni F; Lombardi G; Calzà L; Agnati LF
Brain Res; 1984 Apr; 296(2):233-9. PubMed ID: 6142756
[TBL] [Abstract][Full Text] [Related]
2. Effect of GM1 ganglioside treatment on the recovery of dopaminergic nigro-striatal neurons after different types of lesion.
Toffano G; Agnati LF; Fuxe K; Aldinio C; Consolazione A; Valenti G; Savoini G
Acta Physiol Scand; 1984 Nov; 122(3):313-21. PubMed ID: 6151339
[TBL] [Abstract][Full Text] [Related]
3. GM1 ganglioside stimulates the regeneration of dopaminergic neurons in the central nervous system.
Toffano G; Savoini G; Moroni F; Lombardi G; Calza L; Agnati LF
Brain Res; 1983 Feb; 261(1):163-6. PubMed ID: 6132660
[No Abstract] [Full Text] [Related]
4. Further studies on the effects of the GM1 ganglioside on the degenerative and regenerative features of mesostriatal dopamine neurons.
Agnati LF; Fuxe K; Calza L; Goldstein M; Toffano G; Giardino L; Zoli M
Acta Physiol Scand Suppl; 1984; 532():37-44. PubMed ID: 6594030
[TBL] [Abstract][Full Text] [Related]
5. Effects of gangliosides on the functional recovery of damaged brain.
Toffano G; Savoini G; Aldinio C; Valenti G; Dal Toso R; Leon A; Calza L; Zini I; Agnati LF; Fuxe K
Adv Exp Med Biol; 1984; 174():475-88. PubMed ID: 6741741
[TBL] [Abstract][Full Text] [Related]
6. The vigilance-promoting drug modafinil counteracts the reduction of tyrosine hydroxylase immunoreactivity and of dopamine stores in nigrostriatal dopamine neurons in the male rat after a partial transection of the dopamine pathway.
Ueki A; Rosén L; Andbjer B; Finnman UB; Altamimi U; Janson AM; Goldstein M; Agnati LF; Fuxe K
Exp Brain Res; 1993; 93(2):259-70. PubMed ID: 8098283
[TBL] [Abstract][Full Text] [Related]
7. Gangliosides increase the survival of lesioned nigral dopamine neurons and favour the recovery of dopaminergic synaptic function in striatum of rats by collateral sprouting.
Agnati LF; Fuxe K; Calza L; Benfenati F; Cavicchioli L; Toffano G; Goldstein M
Acta Physiol Scand; 1983 Dec; 119(4):347-63. PubMed ID: 6141701
[TBL] [Abstract][Full Text] [Related]
8. GM1 ganglioside does not stimulate reinnervation of the striatum by substantia nigra grafts.
Freed WJ
Brain Res Bull; 1985 Jan; 14(1):91-5. PubMed ID: 3986629
[TBL] [Abstract][Full Text] [Related]
9. Chronic nicotine treatment counteracts the disappearance of tyrosine-hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemitransection.
Janson AM; Fuxe K; Agnati LF; Kitayama I; Härfstrand A; Andersson K; Goldstein M
Brain Res; 1988 Jul; 455(2):332-45. PubMed ID: 2900058
[TBL] [Abstract][Full Text] [Related]
10. Effects of lesions and ganglioside GM1 treatment on striatal polyamine levels and nigral DA neurons. A role of putrescine in the neurotropic activity of gangliosides.
Agnati LF; Fuxe K; Zini I; Davalli P; Corti A; Calza L; Toffano G; Zoli M; Piccinini G; Goldstein M
Acta Physiol Scand; 1985 Aug; 124(4):499-506. PubMed ID: 2864781
[TBL] [Abstract][Full Text] [Related]
11. tGS ganglioside induces peculiar morphological features in grafted dopaminergic cells and promotes motor recovery in rats with unilateral lesions in the nigrostriatal dopamine pathway.
Nishino H; Hashitani T; Isobe Y; Furuyama F; Sato H; Kumazaki M; Horikomi K; Awaya A
Brain Res; 1990 Nov; 534(1-2):73-82. PubMed ID: 1981486
[TBL] [Abstract][Full Text] [Related]
12. The functional recovery of damaged brain: the effect of GM1 monosialoganglioside.
Toffano G; Savoini G; Aporti F; Calzolari S; Consolazione A; Maura G; Marchi M; Raiteri M; Agnati LF
J Neurosci Res; 1984; 12(2-3):397-408. PubMed ID: 6150119
[TBL] [Abstract][Full Text] [Related]
13. GM1 ganglioside restores dopaminergic neurochemical and morphological markers in aged rats.
Goettl VM; Wemlinger TA; Duchemin AM; Neff NH; Hadjiconstantinou M
Neuroscience; 1999; 92(3):991-1000. PubMed ID: 10426539
[TBL] [Abstract][Full Text] [Related]
14. GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study.
Hadjiconstantinou M; Mariani AP; Neff NH
Brain Res; 1989 Apr; 484(1-2):297-303. PubMed ID: 2565752
[TBL] [Abstract][Full Text] [Related]
15. GM1 gangliosides stimulate neuronal reorganization and reduce rotational asymmetry after hemitransections of the nigro-striatal pathway.
Sabel BA; Dunbar GL; Butler WM; Stein DG
Exp Brain Res; 1985; 60(1):27-37. PubMed ID: 3930279
[TBL] [Abstract][Full Text] [Related]
16. GM1 ganglioside protects against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse.
Janson AM; Agnati LF; Fuxe K; Cintra A; Sundstrom E; Zini I; Toffano G; Goldstein M
Acta Physiol Scand; 1988 Apr; 132(4):587-8. PubMed ID: 3265839
[No Abstract] [Full Text] [Related]
17. The effects of L-deprenyl treatment, alone and combined with GM1 ganglioside, on striatal dopamine content and substantia nigra pars compacta neurons.
Rothblat DS; Schneider JS
Brain Res; 1998 Jan; 779(1-2):226-30. PubMed ID: 9473679
[TBL] [Abstract][Full Text] [Related]
18. Reduction of anterograde degeneration in brain damaged rats by GM1-gangliosides.
Sabel BA; DelMastro R; Dunbar GL; Stein DG
Neurosci Lett; 1987 Jun; 77(3):360-6. PubMed ID: 3614768
[TBL] [Abstract][Full Text] [Related]
19. Intranasal infusion of GD3 and GM1 gangliosides downregulates alpha-synuclein and controls tyrosine hydroxylase gene in a PD model mouse.
Itokazu Y; Fuchigami T; Morgan JC; Yu RK
Mol Ther; 2021 Oct; 29(10):3059-3071. PubMed ID: 34111562
[TBL] [Abstract][Full Text] [Related]
20. GM1 ganglioside rescues substantia nigra pars compacta neurons and increases dopamine synthesis in residual nigrostriatal dopaminergic neurons in MPTP-treated mice.
Schneider JS; Kean A; DiStefano L
J Neurosci Res; 1995 Sep; 42(1):117-23. PubMed ID: 8531220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
